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Abstract The purpose of this study is to assess the suc-
cessful incorporation of cages in patients after cervical or
lumbar intercorporal fusion with positron-emission
tomography/computed tomography (PET/CT). Twenty
patients (14 female and 6 male; mean age 58 years, age
range 38–73 years) with 30 cervical (n = 13) or lumbar
(n = 17) intercorporal fusions were prospectively enrolled
in this study. Time interval between last intercorporal
intervention and PET/CT ranged from 2 to 116 months
(mean 63; median 77 months). IRB approval was obtained
for all patients, and written informed consent was obtained
from all patients. About 30 min prior to PET/CT scanning,
97–217 MBq (mean 161 MBq) 18F-fluoride were admin-
istered intravenously. Patients were imaged in supine
position on a combined PET/CT system (Discovery
RX/STE, 16/64 slice CT, GE Healthcare). 3D-PET emis-
sion data were acquired for 1.5 and 2 min/bed position,
respectively, and reconstructed by a fully 3D iterative
algorithm (VUE Point HD) using low-dose CT data for
attenuation correction. A dedicated diagnostic thin-slice
CT was optionally acquired covering the fused region.
Areas of increased 18F-fluoride uptake around cages were
determined by one double-board certified radiologist/
nuclear physician and one board certified radiologist in
consensus. In 12/20 (60%) patients, increased 18F-fluoride
uptake around cages was observed. Of the 30 intercorporal
fusions, 15 (50%) showed increased 18F-fluoride uptake.
Median time between intervention and PET/CT examina-
tion in cages with increased uptake was 37 months
(2–116 months), median time between intervention and
PET/CT examination in those cages without increased
uptake was 91 months (19–112 months), p (Wilcoxon) =
0.01 (one-sided). 14/29 (48%) cages with a time inter-
val [ 1 year between intervention and PET/CT scan
showed an increased uptake. In conclusion, PET/CT fre-
quently shows increased 18F-fluoride uptake in cervical
and lumbar cages older than 1 year (up to almost 8 years in
cervical cages and 10 years in lumbar cages) possibly
indicating unsuccessful fusion due to increased stress/
microinstability.
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Introduction
Cervical and lumbar intercorporal fusions are performed to
treat symptomatic segmental degeneration or instability in
the cervical and lumbar spine [1–4]. A large number of
studies assessing outcome in patients after spine surgery
clinically, to a lesser extent by (combined) morphological
and functional imaging techniques, e.g. bone SPECT and
[(18)F]fluoride positron-emission tomography/computed
tomography (PET/CT), have been performed since the late
1980s. Special interest is put on patients who lack osseous
fusion after surgery including intercorporal fusions [4–11].
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18F-labeled NaF was already used for bone scintigraphy
by Blau et al. in the early 1960s. Aftermath due to technical
and availability reasons, 99mTc-labeled bone seeking
agents like 99mTc-methylene diphosphonate (MDP) were
preferred for bone scanning. In the early 1990s, 18F-fluo-
ride was readopted for PET scanning [12].
18F-fluoride is a tracer depicting blood flow and
osteoblastic activity. After i.v. administration, 18F-fluo-
ride diffuses from the bone capillaries into the bone
extracellular fluid (ECF). Its plasma clearance is more
rapid and its single-passage extraction efficiency is higher
compared to 99mTc-MDP due to its smaller molecular
weight and its negligible protein binding. From the bone
ECF, 18F-fluoride is taken up to form the mineral fluor-
apatite at the surface of bone crystals especially at sites of
bone remodeling with high turnover. Its bone uptake is
approximately twofold greater than that of the conven-
tional tracer 99mTc-MDP and its blood to bone clearance
reaches almost 100%, with the fast blood clearance
resulting in a better target-to-background ratio. As a fur-
ther advantage, 18F-fluoride allows imaging shortly (in
our protocol about 30 min) after i.v. administration in
contrast to 99mTc-MDP [13, 14]. The current work pre-
sents a prospective study analyzing 18F-fluoride uptake
around cages in patients after cervical and/or posterior
lumbar intercorporal fusion. It is hypothesized that
increased stress/microinstability and thus missing or
incomplete osseous intercorporal fusion shows concomi-
tant increased 18F-fluoride uptake. It was investigated
how long after last intercorporal intervention increased
uptake can be observed.
Patients and methods
Patient selection
20 patients (14 female and 6 male; mean age 58 years, age
range 38–73 years) with 30 intercorporal cervical (13/30) or
lumbar (17/30) fusions were prospectively enrolled in this
study between March 2008 and March 2009 (Table 1). We
received approval from our Institutional Review Board
(IRB) as well as written informed consent of each patient.
Time interval between last intercorporal intervention and
PET/CT examination ranged from 2 to 116 months (mean
63 months; median 77 months). Patients had chronic back
pain, the vast majority of the lower/lumbar spine. No clinical
suspicion of infection was given. Only titan containing
cages with autologous bone grafts had been implanted
(Table 2).
Radiochemistry
18F-fluoride was produced by proton irradiation of 18O-
enriched water (RWE Nukem) in a cyclotron (PETtrace
200, GE Medical systems). After an irradiation for other
18F tracers, the cyclotron target was rinsed with water for
injection to recover the remaining 18F-fluoride. The
Table 1 20 patients with
cervical and/or lumbar
intercorporal fusions
Gender (f female, m male), Age
(in years), Activitiy
administered (in MBq), time
and number of in-house-
surgeries
Patient no. Gender Age MBq Time of surgeries No. of in-house-surgeries
1 f 64 145 2000–2007 6
2 m 67 215 2004–2007 7
3 m 70 180 2004–2005 2
4 f 65 175 2007–2008 2
5 f 55 97 1999–2005 3
6 m 62 184 1999–2007 5
7 f 70 155 2002–2008 8
8 m 52 217 2001–2006 5
9 f 63 175 2002–2004 6
10 f 38 136 2006–2007 3
11 f 60 214 2001 1
12 m 48 158 1999–2002 2
13 f 62 125 2007 1
14 f 73 156 2000–2005 3
15 f 48 124 2000–2005 2
16 f 39 116 1998–2003 4
17 f 47 153 2001–2007 4
18 f 54 129 1999–2001 2
19 f 59 172 1998–2004 7
20 m 56 194 2004–2008 3
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recovered amount was sufficient for up to eight patients.
The 18F-fluoride in the target flush water was then purified
and formulated in 0.9% sodium chloride for injection by an
automated synthesis unit (FASTlab, GE Medical systems).
The quality control for the sodium 18F-fluoride injection
solution was according to the European Pharmacopoeia.
The radiochemical and radionuclide purity was [98.5 and
[99.9%, respectively.
Fluoride PET/CT scanning
We used a combined PET/CT system (Discovery RX or
Discovery STE, GE Healthcare, Milwaukee, WI). This
device integrates a PET scanner with a multi-slice helical
CT (16 or 64 slices) and permits the acquisition of coreg-
istered CT and PET images in the same session. Scanning
started approximately 30–45 min after the i.v. injection of
a dose of 97–217 MBq, mean 161 MBq of 18F-fluoride.
Patients were examined in supine position. Immediately
following the low-dose CT acquisition (FOV 50 cm,
80 mA, 120 kV, slice thickness 3.75 mm, 0.5 s rotation
time, standard reconstruction type), 3D-PET emission data
were acquired for 1.5 and 2 min/bed position, respectively.
The CT data were used for attenuation correction and
images were reconstructed using a fully 3D iterative
algorithm (VUE Point HD).
Additionally, a dedicated thin-slice CT (0.625 mm),
FOV 50 cm, 0.5 s rotation time, smartmA (maximum 440
and 700 mA), 120 kV, was acquired optionally covering
the fused region (standard and bone reconstruction type).
Diagnostic thin-slice CTs were available of cervical
cages in 3/8 patients and of lumbar cages in all 15 patients.
The acquired images were postprocessed with a dedicated
software (Volume Viewer PET/CT, AW 4.4 workstation,
GE Healthcare) providing multiplanar reformatted images
of PET alone, CT alone and fused PET/CT with linked
cursors.
PET/CT evaluation
PET/CT images were analyzed in consensus by a double-
board certified radiologist and nuclear physician with special











1 C4/5, 5/6, 6/7 – 92 (39) 0, 0, 1 ID HWS Cage, Titanium (39)
2 – L5/S1 (left) 17 1 Telamon Titanium
3 C5/6, 6/7 – 30 (29) 1, 1 ID HWS Cage, Titanium (29)
4 – L4/5 13 1 Telamon Titanium
5 – L4/5, L5/S1 102 (L4/5), 35 (L5/S1) 0, 0 ProSpace Titanium, Telamon Titanium
6 – L4/5 107 0 ProSpace Titanium
7 C5/6 L2/3, L4/5 37 (C5/6), 2 (L2/3), 69 (L4/5) 1, 1, 0 ID HWS Cage, Titanium, KZC,
Titaniumb, ProSpace Titanium
8 C3/4, C4/5 L5/S1 79 (C3–5), 80 (L5/S1) 1, 1, 0 ID HWS Cage, Titanium (29),
ProSpace Titanium
9 – L4/5 47 1 Telamon Titanium
10 – L5/S1 27 1 Telamon Titanium
11 C5/6 – 90 0 ID HWS Cage, Titanium
12 – L5/S1 112 0 Diapason Titanium
13 – L4/5 19 0 Telamon Titanium
14 – L4/5 100 0 ProSpace Titanium
15 C5/6, C6/7 – 34 (29) 0, 0 ID HWS Cage, Titanium (29)
16 – L5/S1 116 1 Harms Titanium
17 – L5/S1 74 1 ProSpace Titanium
18 C5/6 – 84 1 ID HWS Cage, Titanium
19 C5/6 L3/4 91 (C5/6), 106 (L3/4) 0, 0 ID HWS Cage, Titanium,
ProSpace Titanium
20 – L5/S1 14 1 ProSpace Titanium
ID Implant design
a Material named includes registered trademarks 
b KZC Karl Zweifel Cage
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training in musculoskeletal radiology and 5 years experi-
ence in PET/CT reading and one board certified radiologist
with 1 year experience in PET/CT reading. The readers were
blinded regarding the results of any previous imaging.
Attenuation-corrected PET images as well as fused PET/CT
images were used for analysis, using the CT for anatomical
correlation. Increased 18F-fluoride uptake around cages
higher than normal appearing bone was interpreted as patho-
logic regardless of pathological changes on CT.
Statistical evaluation
Evaluation was done using nonparametric procedures in
SAS 9.2. For comparisons between groups, Wilcoxon two-
sample tests were applied using normal approximation to
Z. Values for one-sided tests are displayed considering the
alternative hypothesis of shorter time distance between
intervention and PET/CT scan in patients with increased
18F-fluoride uptake around cages.
Results
PET/CT findings
In 12/20 (60%) patients, increased 18F-fluoride uptake
around intercorporal fusion material was found. 15/30
(50%) cages showed increased fluoride uptake. Median
time between intervention and PET/CT in cages with
increased uptake was 37 months (2–116 months, N = 15,
interquartile range = 62), median time between interven-
tion and PET/CT in those cages without increased uptake
was 91 months (19–112 months, N = 15, interquartile
range = 67), p (Wilcoxon) = 0.01 (one-sided) (Table 2).
Analyzing cervical and lumbar intercorporal fusions
separately, there were 7/13 (54%) cervical cages showing
increased uptake and 8/17 (47%) lumbar cages with
increased uptake. Median time between intervention and
PET/CT in cervical cages with increased uptake was
79 months (30–92 months, N = 7, interquartile range =
54), median time between intervention and PET/CT in
cervical cages without increased uptake was 90.5 months
(34–92 months, N = 6, interquartile range = 58), p (Wil-
coxon) = 0.14 (one-sided). Median time between inter-
vention and PET/CT in lumbar cages with increased uptake
was 22 months (2–116 months, N = 8, interquartile
range = 47), median time between intervention and PET/
CT in lumbar cages without increased uptake was
100 months (19–112 months, N = 9, interquartile range =
37), p (Wilcoxon) = 0.02 (one-sided).
Regarding cervical intercorporal fusions, there were four
patients with more than one intervertebral fusions, three
with two adjacent segments either both with or without
increased uptake. One patient had received three adjacent
intercorporal fusions of which only the lowest showed
increased uptake (Figs. 1, 2, 3).
Fig. 1 64-year-old female
patient 92 months
postoperatively with the lowest
of three cervical cages (C4/5,
C5/6, C6/7) showing increased
fluoride uptake (patient no. 1).
Sagittal low-dose CT, fused
PET/CT, PET
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Regarding lumbar intercorporal fusions, there were two
patients with two intercorporal fusions showing either both
no increased uptake or one an increased uptake (Figs. 4, 5).
Three patients had received both cervical and lumbar
intercorporal fusions only one of them showing no
increased uptake in both regions (Fig. 6).
Discussion
This study shows that even in those cervical and lumbar
cages with a time interval of more than 1 year between
surgery and fluoride PET/CT, increased 18F-fluoride
uptake can be observed. The longest time interval in
Fig. 2 52-year-old male patient
79 months postoperatively with
both cervical cages (C3/4, C4/5)
showing increased uptake
(patient no. 8). Sagittal low-
dose CT, fused PET/CT, PET




cervical cages (C5/6, C6/7)
(patient no. 15). Sagittal low-
dose CT, fused PET/CT, PET
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lumbar cages with increased uptake was 116 months
(almost 10 years) and in cervical cages 92 months (almost
8 years), though there was a significant difference in
median time between PET/CT and last intercorporal
intervention between the group of cages with and without
increased uptake (p = 0.01). If one takes the group of
cervical and lumbar cages separately, only the group of
lumbar cages shows a significant difference in median time
between PET/CT and last intercorporal intervention
(p = 0.14 in cervical cages, p = 0.02 in lumbar cages).
Median time between PET/CT and last intercorporal
intervention in cages with increased uptake is 37 months in
all cages, 79 months in cervical and 22 months in lumbar
cages. In contrast, median time between PET/CT and last
Fig. 4 55-year-old female
patient 102 and 35 months
postoperatively with no
increased uptake around both
lumbar/lumbosacral cages (L4/
5, L5/S1) (patient no. 5).
Sagittal low-dose CT, fused
PET/CT, PET
Fig. 5 70-year-old female
patient 2 and 69 months
postoperatively with increased
uptake around one lumbar cage
(L2/3) and no increased uptake
around the other lumbar cage
(L4/5) (patient no. 7). Sagittal
low-dose CT, fused PET/CT,
PET. Note additional increased
uptake in fractured end-plate L1
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intercorporal intervention in cages without increased
uptake is 91 months in all cages, 90.5 months in all cer-
vical and 100 months in all lumbar cages. This is a small
study group and it needs to be verified whether incorpo-
ration of cervical cages indeed takes longer than in lumbar
cages. These results show that even many years after cage
implantation, there can be increased fluoride uptake which
is likely an expression of increased stress, overcharge and
microinstability even in morphologically unsuspicious
segments. It is also possible that cages show increased
uptake after having formerly been metabolically silent due
to secondary loosening. This information is only obtained
by the functional PET part. Until now, most studies focus
on morphological imaging techniques to evaluate the
healing process of intercorporal fusions. Obviously, there
seems to be no uniform radiological criteria for assessing
intercorporal fusion by plain radiographs or CT [10, 15–
18]. 18F-fluoride PET/(CT) on the contrary has mostly
been used in the assessment of malignant bone abnormal-
ities [19–23]. However, promising results are also found in
benign bone disorders, e.g. in the spine [11]. Considering
our study results, 18F-fluoride PET/CT might potentially
play an increasing role in the evaluation of the postopera-
tive spine, supporting and complementing diagnostic cri-
teria to assess intercorporal fusion after surgery. The
supplement of PET to CT information in this study seems
to help either to support diagnosis of non-fusion or to
confirm the diagnosis of complete fusion. As 18F-fluoride
is taken up to form the mineral fluorapatite at the surface of
bone crystals especially at sites of bone remodeling with
high turnover [14], segments with increased uptake around
cages compared to adjacent bony structures might be
considered as non-fused and those with the same uptake as
fused in a metabolic sense. Hence, 18F-fluoride PET/CT
possibly has an impact on therapeutic decisions. By
avoiding unnecessary surgery, costs would decrease [24].
Although we did not correlate increased uptake with
pain in the present study, it is possible that fluoride PET/
CT can provide additional functional information to
explain persistent pain in patients after intercorporal
fusion surgery. In this study group, no difference was
made concerning different cage types or graft material,
due to the limited number and as only titanium containing
cages and autologous grafts were used for fusion. A next
step would be to compare fusion rates in different cage
types and grafts (autologous, allogenic, bone graft sub-
stitutes) [25–30].
This study has several limitations. The study group is
limited. No correlation with surgical re-exploration was
done. Patients had mostly more than one spinal surgery
(Table 1). Therefore, a bias concerning study population
cannot be excluded. Also, only attenuation-corrected ima-
ges were evaluated. Nevertheless, it was possible to dif-
ferentiate cages with and without surrounding uptake in
one patient (Figs. 1, 5).
Additional non-attenuation-corrected images might help
diagnosing cases with rather faint surrounding uptake.
Furthermore, it would be of interest to differentiate fusion
rates in cages with and without additional (multisegmental)
anterior or posterior fusion.
Fig. 6 59-year-old female
patient 91 and 106 months
postoperatively with no
increased uptake either around
her cervical (C5/6) or lumbar
cage (L3/4) (patient no 19).
Sagittal low-dose CT, fused
PET/CT, PET
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The effective dose equivalent for 18F-fluoride is
0.023 mSv/MBq, which corresponds to a maximum
effective dose equivalent of about 5 mSv in this study [31].
With this protocol, the radiation burden of a fluoride PET/
CT is slightly superior to conventional SPECT/CT [12]. An
administered activity of 100–200 MBq (corresponding to
an effective dose equivalent of about 2.3–4.6 mSv) is quite
adequate to provide diagnostic images. Another advantage
is the short uptake time of 18F-fluoride allowing imaging
quickly after administration [13]. One clear limitation is
the limited availability of 18F-fluoride and number of PET/
CT systems as well as the higher incremental costs of 18F-
fluoride PET compared to planar and SPECT bone scin-
tigraphy (BS). Nevertheless, 18F-fluoride PET/(CT) is an
imaging modality which outperforms SPECT BS at least
regarding spatial resolution and generates increasing
interest with the worldwide shortage of molybdenum sup-
ply [12, 14, 32, 33].
Conclusion
Even around cages with a long time interval between sur-
gery and fluoride PET/CT imaging (close to 8 years in
cervical cages and 10 years in lumbar cages), increased
uptake could be observed possibly indicating increased
stress/microinstability and thus missing/incomplete osse-
ous fusion.
This study was approved by the Institutional Review
Board (IRB) and Swissmedic was duly notified. Amend-
ments to the protocol for this study, suppressing bone scans
and extending the number of subjects were also approved
by the IRB; however, it was omitted to notify Swissmedic
about these amendments.
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